Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5903474

NCCCOCCOCCOCCCNC(=O)c1cc(C(=O)NCCCOCCOCCOCCCN)cc(C(=O)NCCCOCCOCCOCCCN)c1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ RHOC P08134 1/20 0.43
▸ RHOA P61586 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CHRNA1 P02708 2/20 0.41
▸ CHRNG P07510 2/20 0.41
▸ CHRNB1 P11230 2/20 0.41
▸ CHRND Q07001 2/20 0.41
▸ MLYCD O95822 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL21806100 0.82 HDAC3 (0.49) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
SCHEMBL8816224 0.79 NTRK2 (0.46) SMN1; SMN2HPGDNPC1RAB9ARHOC
SCHEMBL25766759 0.77 ALDH1A1 (0.61) SMN1; SMN2HPGDALDH1A1CHRNA1CHRNG
SCHEMBL17884625 0.77 ALDH1A1 (0.61) SMN1; SMN2HPGDALDH1A1CHRNA1CHRNG
Trifluoroacetic Acid SCHEMBL22121275 0.77 MLYCD (0.56) SMN1; SMN2HPGDNPC1RAB9AGAA
SCHEMBL27328060 0.77 SMN1; SMN2 (0.52) SMN1; SMN2
Trifluoroacetic Acid SCHEMBL18334635 0.76 SMN1; SMN2 (0.41) SMN1; SMN2RAB9AMAPTLMNA
SCHEMBL8816476 0.76 HPGD (0.55) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
SCHEMBL14758320 0.74 HPGD (0.52) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
Trifluoroacetic Acid SCHEMBL30196351 0.74 TERT (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7141676-B1 Water soluble multi-biotin-containing compounds UNIVERSITY OF WASHINGTON (US) 2006-11-28 — — US disclosed
US-20060228325-A1 Water soluble multi-biotin-containing compounds WILBUR D S 2006-10-12 — — US disclosed
EP-1196199-A4 WATER SOLUBLE MULTI-BIOTIN-CONTAINING COMPOUNDS UNIV WASHINGTON (US) 2002-06-19 — — EP disclosed
EP-1196199-A2 WATER SOLUBLE MULTI-BIOTIN-CONTAINING COMPOUNDS University of Washington (US) 2002-04-17 — — EP disclosed
WO-2000072802-A2 WATER SOLUBLE MULTI-BIOTIN-CONTAINING COMPOUNDS UNIVERSITY OF WASHINGTON (US) 2000-12-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060228325-A1 Water soluble multi-biotin-containing compounds BTD, HLCS, VNN1 SMN1; SMN2 4237/4885HPGD 556/4885NPC1 3667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback